JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

A

133.98

-1.27%↓

JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

A

133.98

-1.27%↓

JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

A

133.98

-1.27%↓

JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

A

133.98

-1.27%↓

JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

A

133.98

-1.27%↓

Search

AmerisourceBergen Corporation

Отворен

СекторЗдравеопазване

0

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Ключови измерители

By Trading Economics

Приходи

-1B

-340M

Продажби

3.1B

84B

P/E

Средно за сектора

44.662

90.422

EPS

3.84

Дивидентна доходност

0.62

Марж на печалбата

-0.406

Служители

47,000

EBITDA

-1.1B

183M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+14.65% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.62%

2.13%

Следващи печалби

4.02.2026 г.

Следваща дата на дивидент

2.03.2026 г.

Следваща дата на екс-дивидент

13.02.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

2.9B

69B

Предишно отваряне

0

Предишно затваряне

0

Настроения в новините

By Acuity

58%

42%

294 / 352 Класиране в Healthcare

AmerisourceBergen Corporation Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

27.01.2026 г., 23:07 ч. UTC

Печалби

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27.01.2026 г., 21:27 ч. UTC

Печалби

Texas Instruments 4Q Sales Rise, Profit Falls

27.01.2026 г., 23:55 ч. UTC

Пазарно говорене

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27.01.2026 г., 23:47 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

27.01.2026 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27.01.2026 г., 23:39 ч. UTC

Пазарно говорене

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27.01.2026 г., 23:20 ч. UTC

Печалби

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27.01.2026 г., 23:20 ч. UTC

Печалби

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27.01.2026 г., 23:19 ч. UTC

Печалби

SK Innovation Posts Net Loss for Second Consecutive Year

27.01.2026 г., 23:19 ч. UTC

Печалби

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27.01.2026 г., 23:18 ч. UTC

Печалби

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27.01.2026 г., 23:18 ч. UTC

Печалби

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27.01.2026 г., 23:11 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

27.01.2026 г., 23:11 ч. UTC

Пазарно говорене

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27.01.2026 г., 23:07 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27.01.2026 г., 22:17 ч. UTC

Пазарно говорене

U.S. Dollar Slips Following Trump Comments -- Market Talk

27.01.2026 г., 22:06 ч. UTC

Печалби

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27.01.2026 г., 21:51 ч. UTC

Печалби

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

27.01.2026 г., 21:43 ч. UTC

Печалби

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27.01.2026 г., 21:41 ч. UTC

Печалби

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27.01.2026 г., 21:38 ч. UTC

Печалби

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27.01.2026 г., 21:32 ч. UTC

Печалби

Ampol: Modest Profit From F&I International in 2025

27.01.2026 г., 21:32 ч. UTC

Печалби

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27.01.2026 г., 21:31 ч. UTC

Печалби

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27.01.2026 г., 21:31 ч. UTC

Печалби

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27.01.2026 г., 21:30 ч. UTC

Печалби

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27.01.2026 г., 21:29 ч. UTC

Печалби

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27.01.2026 г., 21:29 ч. UTC

Печалби

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27.01.2026 г., 21:28 ч. UTC

Печалби

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Сравнение с други в отрасъла

Ценова промяна

AmerisourceBergen Corporation Прогноза

Ценова цел

By TipRanks

14.65% нагоре

12-месечна прогноза

Среден 408.3 USD  14.65%

Висок 440 USD

Нисък 371 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за AmerisourceBergen Corporation през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

11 ratings

10

Купи

1

Задържане

0

Продай

Настроение

By Acuity

294 / 352 Класиране в Здравеопазване

Настроения в новините

Мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно AmerisourceBergen Corporation

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat